Mesoglycan, Vascular Reactivity and Metabolic Syndrome

NCT02254850 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome

Interventions

PROCEDURE: Flow Mediated Dilation
DRUG: Mesoglycan
DRUG: Mesoglycan
DRUG: Placebo
DRUG: Placebo

Sponsor

Federico II University